Bay Street News, March 27th, 2025

Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S. mRNA-LNP […]

HERZLIYA, Israel and BRISTOL, United Kingdom, March 27, 2025 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global […]

Initiated VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune®HPV in HPV16-Positive Head and Neck Cancer Conference call and webcast today at […]

TORONTO, March 27, 2025 (GLOBE NEWSWIRE) — Sparton Resources Inc. (TSXV-SRI) (“Sparton” or the “Company”) announced today that it has […]

OTTAWA, Ontario, March 27, 2025 (GLOBE NEWSWIRE) — Telesat (NASDAQ and TSX: TSAT), one of the world’s largest and most […]

TORONTO, March 27, 2025 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company […]

            Record full-year 2024 HIFU revenue of USD 25.7 million, an increase of 15.3% over full-year […]

FLORHAM PARK, N.J., March 27, 2025 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage […]

Increases Hudbay’s exposure to a long-life, high-quality copper asset in Canada, a tier-1 mining jurisdiction Low upfront and deferred cash […]

TORONTO, March 27, 2025 (GLOBE NEWSWIRE) — Hudbay Minerals Inc. (“Hudbay” or the “company”) (TSX, NYSE: HBM) today released its […]